PolyPid Ltd. Ordinary Shares
Symbol: PYPD (NASDAQ)
Company Description:
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $3.45
- Yesterday High: $3.5178
- Yesterday Low: $3.45
- Yesterday Volume: 17.76K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
- Name: PolyPid Ltd. Ordinary Shares
- Website: https://www.polypid.com
- Listed Date: 2020-06-26
- Location: ,
- Market Status: Active
- CIK Number: 0001611842
- SIC Code:
- SIC description:
- Market Cap: $54.85M
- Round Lot: 100
- Outstanding Shares: 15.90M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-08 | SCHEDULE 13G/A | View |
2025-08-13 | 6-K | View |
2025-08-13 | S-8 | View |
2025-08-13 | SCHEDULE 13G/A | View |
2025-08-13 | 6-K | View |
2025-08-12 | 6-K | View |
2025-08-06 | EFFECT | View |
2025-08-04 | CORRESP | View |
2025-08-04 | UPLOAD | View |
2025-07-29 | SCHEDULE 13G | View |
2025-07-29 | F-3 | View |
2025-07-15 | 6-K | View |
2025-06-25 | 6-K | View |
2025-06-23 | D | View |
2025-06-17 | 6-K | View |
2025-06-09 | 6-K | View |
2025-05-30 | 6-K | View |
2025-05-28 | SCHEDULE 13G/A | View |
2025-05-21 | 6-K | View |
2025-05-15 | SCHEDULE 13G/A | View |